Choi, S.W.; Kim, J.; Jang, G.W.; Lee, Y.S.; Park, J.S.; Lee, J.M.; Kim, H.O.; Chung, H.; Woo, J.S.; Kim, W.S.;
et al. Acute Effect of Evolocumab on Lipoprotein(a) Level and Inflammation in Patients with Coronary Artery Disease. J. Cardiovasc. Dev. Dis. 2022, 9, 101.
https://doi.org/10.3390/jcdd9040101
AMA Style
Choi SW, Kim J, Jang GW, Lee YS, Park JS, Lee JM, Kim HO, Chung H, Woo JS, Kim WS,
et al. Acute Effect of Evolocumab on Lipoprotein(a) Level and Inflammation in Patients with Coronary Artery Disease. Journal of Cardiovascular Development and Disease. 2022; 9(4):101.
https://doi.org/10.3390/jcdd9040101
Chicago/Turabian Style
Choi, Seung Woo, Joan Kim, Gyeong Won Jang, Young Shin Lee, Jin Sun Park, Jung Myung Lee, Hyung Oh Kim, Hyemoon Chung, Jong Shin Woo, Woo Shik Kim,
and et al. 2022. "Acute Effect of Evolocumab on Lipoprotein(a) Level and Inflammation in Patients with Coronary Artery Disease" Journal of Cardiovascular Development and Disease 9, no. 4: 101.
https://doi.org/10.3390/jcdd9040101
APA Style
Choi, S. W., Kim, J., Jang, G. W., Lee, Y. S., Park, J. S., Lee, J. M., Kim, H. O., Chung, H., Woo, J. S., Kim, W. S., & Kim, W.
(2022). Acute Effect of Evolocumab on Lipoprotein(a) Level and Inflammation in Patients with Coronary Artery Disease. Journal of Cardiovascular Development and Disease, 9(4), 101.
https://doi.org/10.3390/jcdd9040101